Verrica Pharmaceuticals

(NASDAQ) VRCA

Current Price$5.91

Market Cap$101.35M

Since IPO (2018)-97%

5 Year-95%

1 Year-7%

1 Month-7%

Verrica Pharmaceuticals Financials at a Glance

Market Cap

$101.35M

Revenue (TTM)

$37.16M

Net Income (TTM)

$17.83M

EPS (TTM)

$-1.03

P/E Ratio

-5.71

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$5.91

Volume

35,398

Open

$5.91

Price

$5.91

Volume

35,398

Open

$5.91

Previous Close

$5.90

Daily Range

$5.71 - $6.15

52-Week Range

$3.28 - $9.82

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$5.91

Volume

35,398

Open

$5.91

Previous Close

$5.90

Daily Range

$5.71 - $6.15

52-Week Range

$3.28 - $9.82

VRCA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Verrica Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Jayson M. Rieger, PhD, MBA

Website

www.verrica.com

Headquarters

West Chester, PA 19380, US

VRCA Financials

Key Financial Metrics (TTM)

Gross Margin

90%

Operating Margin

-36%

Net Income Margin

-48%

Return on Equity

-240%

Return on Capital

-60%

Return on Assets

-46%

Earnings Yield

-17.51%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$101.35M

Shares Outstanding

17.18M

Volume

35.40K

Avg. Volume

106.16K

Financials (TTM)

Gross Profit

$32.14M

Operating Income

$11.94M

EBITDA

$9.36M

Operating Cash Flow

$17.63M

Capital Expenditure

$0.00

Free Cash Flow

$17.63M

Cash & ST Invst.

$30.15M

Total Debt

$1.63M

Verrica Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$5.02M

+46.1%

Gross Profit

$4.13M

+37.1%

Gross Margin

82.30%

N/A

Market Cap

$101.35M

N/A

Market Cap/Employee

$1.43M

N/A

Employees

N/A

Net Income

$9.68M

+0.6%

EBITDA

$9.52M

-29.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$19.16M

+249.2%

Accounts Receivable

$7.81M

+38.2%

Inventory

$1.97M

-19.7%

Long Term Debt

$698.00K

-97.6%

Short Term Debt

$744.00K

-94.5%

Return on Assets

-45.96%

N/A

Return on Invested Capital

-59.93%

N/A

Free Cash Flow

$9.16M

+27.7%

Operating Cash Flow

$9.16M

+27.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

QTTBQ32 Bio Inc.

QTTBQ32 Bio Inc.$5.50-3.00%

ANTXAN2 Therapeutics, Inc.

ANTXAN2 Therapeutics, Inc.$4.89+6.54%

SABSSAB Biotherapeutics, Inc.

SABSSAB Biotherapeutics, Inc.$3.81+3.53%

GBIOGeneration Bio Co.

GBIOGeneration Bio Co.$5.34+0.00%

MURAMural Oncology plc

MURAMural Oncology plc$2.04+0.00%

BOLDBoundless Bio, Inc.

BOLDBoundless Bio, Inc.$1.45+2.11%

NXTCNextCure, Inc.

NXTCNextCure, Inc.$10.20+5.75%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NIONio

NIONio$5.60+0.00%

QBTSD-Wave Quantum

QBTSD-Wave Quantum$25.74+0.33%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.72+0.00%

NOKNokia

NOKNokia$14.18+0.04%

FFord Motor Company

FFord Motor Company$13.66+0.03%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.95+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.96-0.01%

Questions About VRCA

What is the current price of Verrica Pharmaceuticals?

Verrica Pharmaceuticals is trading at $5.90 per share.

What is the 52-week range for Verrica Pharmaceuticals?

Over the past 52 weeks, Verrica Pharmaceuticals has traded between $3.28 and $9.82.

How much debt does Verrica Pharmaceuticals have?

As of the most recent reporting period, Verrica Pharmaceuticals reported total debt of $1.44M.

How much cash does Verrica Pharmaceuticals have on hand?

Verrica Pharmaceuticals reported $20.60M in cash and cash equivalents in its most recent financial results.

What is Verrica Pharmaceuticals’s dividend yield?

Verrica Pharmaceuticals does not currently have a dividend yield.

Verrica Pharmaceuticals

Verrica Pharmaceuticals Financials at a Glance

VRCA News

Verrica Posts Profit in Fiscal Q2

Why Shares of Verrica Pharmaceuticals Are Plummeting on Monday

Why Verrica Pharmaceuticals Stock Is Getting Pummeled Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Verrica Pharmaceuticals

VRCA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Verrica Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VRCA

What is the current price of Verrica Pharmaceuticals?

What is the 52-week range for Verrica Pharmaceuticals?

How much debt does Verrica Pharmaceuticals have?

How much cash does Verrica Pharmaceuticals have on hand?

What is Verrica Pharmaceuticals’s dividend yield?

Premium Investing Services